These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33239887)

  • 1. Secretory Pathway Kinase
    Du S; Guan S; Zhu C; Guo Q; Cao J; Guan G; Cheng W; Cheng P; Wu A
    Onco Targets Ther; 2020; 13():11755-11768. PubMed ID: 33239887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
    Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH
    CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma.
    Phan TL; Kim HJ; Lee SJ; Choi MC; Kim SH
    Onco Targets Ther; 2021; 14():4867-4878. PubMed ID: 34588781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
    Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
    Front Oncol; 2019; 9():1433. PubMed ID: 31921684
    [No Abstract]   [Full Text] [Related]  

  • 5. PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
    Sun J; Xu Y; Liu J; Cui H; Cao H; Ren J
    Cancer Sci; 2022 Feb; 113(2):500-516. PubMed ID: 34812552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.
    Zhang LY; Guo Q; Guan GF; Cheng W; Cheng P; Wu AH
    Front Oncol; 2019; 9():904. PubMed ID: 31616629
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.
    Guo Q; Guan GF; Cao JY; Zou CY; Zhu C; Cheng W; Xu XY; Lin ZG; Cheng P; Wu AH
    J Cell Physiol; 2019 Sep; 234(9):15496-15509. PubMed ID: 30693511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic and transcriptional activation of the secretory kinase FAM20C as an oncogene in glioma.
    Gong B; Liang Y; Zhang Q; Li H; Xiao J; Wang L; Chen H; Yang W; Wang X; Wang Y; He Z
    J Genet Genomics; 2023 Jun; 50(6):422-433. PubMed ID: 36708808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
    Ye N; Jiang N; Feng C; Wang F; Zhang H; Bai HX; Yang L; Su Y; Huang C; Wanggou S; Li X
    J Cancer; 2019; 10(22):5536-5548. PubMed ID: 31632497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.
    Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q
    Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma.
    Feng J; Zhou J; Zhao L; Wang X; Ma D; Xu B; Xie F; Qi X; Chen G; Zhao H; Wu J
    Front Genet; 2021; 12():757014. PubMed ID: 34970298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Five-Pseudogene Signature for Predicting Survival and Its ceRNA Network in Glioma.
    Wang Y; Liu X; Guan G; Xiao Z; Zhao W; Zhuang M
    Front Oncol; 2019; 9():1059. PubMed ID: 31681595
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell infiltration and drug response in glioblastoma multiforme: insights from oxidative stress-related genes.
    Wang K; Xiao Y; Zheng R; Cheng Y
    Cancer Cell Int; 2024 Apr; 24(1):123. PubMed ID: 38566075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
    Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
    Front Oncol; 2021; 11():611038. PubMed ID: 33937022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
    Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
    J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.